STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment

Cancer immunology research

Volumn 2, Issue 12, 2014, Pages 1199-1208

  Ohkuri, Takayuki ^a   Ghosh, Arundhati ^a   Kosaka, Akemi ^a   Zhu, Jianzhong ^a   Ikeura, Maki ^a   David, Michael ^a   Watkins, Simon C ^a   Sarkar, Saumendra N ^a   Okada, Hideho ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(3',5')-CYCLIC DIGUANYLIC ACID; CANCER VACCINE; CD11B ANTIGEN; CYCLIC GMP; GLYCOPROTEIN P 15095; INTERFERON; MEMBRANE PROTEIN; MPYS PROTEIN, MOUSE;

AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GLIOMA; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MORTALITY; MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; CANCER VACCINES; CELL LINE, TUMOR; CYCLIC GMP; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GLIOMA; INTERFERON TYPE I; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TUMOR MICROENVIRONMENT;

EID: 84964698449     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0099     Document Type: Article

References (0)